These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 22816881

  • 1. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
    Dogra S, Jain A, Kanwar AJ.
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial.
    Mittal R, Malhotra S, Pandhi P, Kaur I, Dogra S.
    Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S, Krishna V, Kanwar AJ.
    Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB, Kanwar AJ, Handa S.
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of acitretin and commercial tanning bed therapy for psoriasis.
    Carlin CS, Callis KP, Krueger GG.
    Arch Dermatol; 2003 Apr; 139(4):436-42. PubMed ID: 12707089
    [Abstract] [Full Text] [Related]

  • 6. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P, Del Giglio M, Cotena C, Girolomoni G.
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial.
    Yu C, Fan X, Li Z, Liu X, Wang G.
    Eur J Dermatol; 2017 Apr 01; 27(2):150-154. PubMed ID: 28400341
    [Abstract] [Full Text] [Related]

  • 8. Low-dose acitretin in treatment of plaque-type psoriasis: descriptive study of efficacy and safety.
    Borghi A, Corazza M, Bertoldi AM, Caroppo F, Virgili A.
    Acta Derm Venereol; 2015 Mar 01; 95(3):332-6. PubMed ID: 24978351
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
    Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM.
    Arch Dermatol; 2009 Mar 01; 145(3):269-71. PubMed ID: 19289755
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of acitretin in severe psoriasis.
    Geiger JM.
    Skin Therapy Lett; 2003 Mar 01; 8(4):1-3, 7. PubMed ID: 12858231
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and Safety of Acitretin in Children with Plaque Psoriasis: A Multicenter Retrospective Analysis.
    Di Lernia V, Bonamonte D, Lasagni C, Belloni Fortina A, Cambiaghi S, Corazza M, Di Nuzzo S, Gisondi P, Panzone M, Guarneri C, Neri I.
    Pediatr Dermatol; 2016 Sep 01; 33(5):530-5. PubMed ID: 27443789
    [Abstract] [Full Text] [Related]

  • 12. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
    Pearce DJ, Klinger S, Ziel KK, Murad EJ, Rowell R, Feldman SR.
    Arch Dermatol; 2006 Aug 01; 142(8):1000-4. PubMed ID: 16924049
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of oxymatrine for treatment and relapse suppression of severe plaque psoriasis: results from a single-blinded randomized controlled clinical trial.
    Zhou H, Shi HJ, Yang J, Chen WG, Xia L, Song HB, Bo KP, Ma W.
    Br J Dermatol; 2017 Jun 01; 176(6):1446-1455. PubMed ID: 28112799
    [Abstract] [Full Text] [Related]

  • 14. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
    Spuls PI, Hooft L.
    Br J Dermatol; 2012 Oct 01; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
    [Abstract] [Full Text] [Related]

  • 15. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
    Akçali C, Guven EH, Kirtak N, Inaloz HS, Ozgoztasi O, Guvenc U.
    J Int Med Res; 2014 Oct 01; 42(5):1118-22. PubMed ID: 25143337
    [Abstract] [Full Text] [Related]

  • 16. Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels.
    Bilia AR, Bergonzi MC, Isacchi B, Antiga E, Caproni M.
    J Pharm Pharmacol; 2018 Jul 01; 70(7):919-928. PubMed ID: 29600580
    [Abstract] [Full Text] [Related]

  • 17. Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
    Gottlieb AB, Griffiths CE, Ho VC, Lahfa M, Mrowietz U, Murrell DF, Ortonne JP, Todd G, Cherill R, Marks I, Emady-Azar S, Paul CF, Multi-Centre Investigator Group.
    Br J Dermatol; 2005 Jun 01; 152(6):1219-27. PubMed ID: 15948985
    [Abstract] [Full Text] [Related]

  • 18. Acitretin.
    Ortiz NE, Nijhawan RI, Weinberg JM.
    Dermatol Ther; 2013 Jun 01; 26(5):390-9. PubMed ID: 24099069
    [Abstract] [Full Text] [Related]

  • 19. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis.
    Ozdemir M, Engin B, Baysal I, Mevlitoğlu I.
    Acta Derm Venereol; 2008 Jun 01; 88(6):589-93. PubMed ID: 19002344
    [Abstract] [Full Text] [Related]

  • 20. Atorvastatin for the treatment of plaque-type psoriasis.
    Faghihi T, Radfar M, Mehrabian Z, Ehsani AH, Rezaei Hemami M.
    Pharmacotherapy; 2011 Nov 01; 31(11):1045-50. PubMed ID: 22026392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.